Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer

BACKGROUND: Pancreatic cancer has a dismal prognosis. One reason is resistance to cytotoxic drugs. Molecularly matched therapies might overcome this resistance but the best approach to identify those patients who may benefit is unknown. Therefore, we sought to evaluate a molecularly guided treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Reissig, T.M., Tzianopoulos, I., Liffers, S.-T., Rosery, V.K., Guyot, M., Ting, S., Wiesweg, M., Kasper, S., Meister, P., Herold, T., Schmidt, H.H., Schumacher, B., Albers, D., Markus, P., Treckmann, J., Schuler, M., Schildhaus, H.-U., Siveke, J.T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265614/
https://www.ncbi.nlm.nih.gov/pubmed/37148593
http://dx.doi.org/10.1016/j.esmoop.2023.101539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265614/
https://www.ncbi.nlm.nih.gov/pubmed/37148593
http://dx.doi.org/10.1016/j.esmoop.2023.101539

Ejemplares similares